Q5105 HCPCS Level II code: Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units
Q5105 is the HCPCS code for “Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
Q5105Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units
Short description: Inj retacrit esrd on dialysi
HCPCS · United States
Medicare details
The indicators CMS publishes with Q5105 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Other carrier priced
- ASC
- Approved for ambulatory surgical centers
- Type of service
- Medical care; ESRD supplies
- BETOS category
- Other drugs
- Added
- Jul 1, 2018
Where Q5105 sits
- 1Q codesTemporary codes
- 2Active code Q5105Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code Q5105 mean?
Q5105 is the HCPCS code for “Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for esrd on dialysis), 100 units” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover Q5105?
CMS lists Q5105’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Other carrier priced”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside Q5105
All Q codesQ5099Injection, ustekinumab-stba (steqeyma), biosimilar, 1 mgQ5100Injection, ustekinumab-kfce (yesintek), biosimilar, 1 mgQ5101Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgramQ5102Injection, infliximab, biosimilar, 10 mgQ5103Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mgQ5104Injection, infliximab-abda, biosimilar, (renflexis), 10 mgQ5106Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 unitsQ5107Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mgQ5108Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mgQ5109Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mgQ5110Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgramQ5111Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg